Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Elisabeth Oppliger Leibundgut · SciRah

Researcher profile · Semantic Scholar

Elisabeth Oppliger Leibundgut

Share profile

Elisabeth Oppliger Leibundgut — researcher profile on SciRah

h-index: 10
Works: 19
Citations: 522

Most-cited papers

Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.
G. Baerlocher, Elisabeth Oppliger Leibundgut, O. Ottmann, G. Spitzer +7 more
2015New England Journal of Medicine197 citations Open access
Semantic Scholar
Molecular diagnostics of myeloproliferative neoplasms
S. Langabeer, H. Andrikovics, J. Asp, B. Bellosillo +14 more
2015European Journal of Haematology82 citations
Semantic Scholar
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL).
U. Novak, Elisabeth Oppliger Leibundgut, J. Hager, D. Mühlematter +14 more
2002Blood42 citations
Semantic Scholar
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
H. White, Matthew Salmon, F. Albano, C. Andersen +57 more
2022Leukemia36 citations Open access
Semantic Scholar
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV
S. Saussele, R. Hehlmann, A. Fabarius, S. Jeromin +20 more
2018Leukemia34 citations Open access
Semantic Scholar
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05).
F. Zappa, C. Droege, D. Betticher, R. von Moos +14 more
2012Lung Cancer33 citations
Semantic Scholar
Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial.
P. Froesch, M. Mark, S. Rothschild, Qi-Yu Li +10 more
2021Lung Cancer16 citations
Semantic Scholar
Imetelstat inhibits growth of megakaryocyte colony-forming units from patients with essential thrombocythemia.
G. Baerlocher, M. Haubitz, Thomas R. Braschler, C. Brunold +3 more
2019Blood Advances16 citations Open access
Semantic Scholar
Targeting Telomere Biology in Acute Lymphoblastic Leukemia
A. Karow, M. Haubitz, Elisabeth Oppliger Leibundgut, I. Helsen +8 more
2021International Journal of Molecular Sciences15 citations Open access
Semantic Scholar
Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemia
M. Sula, U. Bacher, Elisabeth Oppliger Leibundgut, B. Mansouri-Taleghani +2 more
2019Bone Marrow Transplantation12 citations Open access
Semantic Scholar
Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110-FGFR1 Rearrangement.
M. Wehrli, Elisabeth Oppliger Leibundgut, H. Gattiker, M. Manz +2 more
2017The Oncologist10 citations Open access
Semantic Scholar
International external quality assurance of JAK2 V617F quantification
J. Asp, V. Skov, B. Bellosillo, T. Kristensen +30 more
2018Annals of Hematology7 citations Open access
Semantic Scholar
Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia
Elisabeth Oppliger Leibundgut, N. Porret, Marianne Bienz Muggli, H. Baumgartner +2 more
2012Annals of Hematology6 citations Open access
Semantic Scholar
Identification of four novel splice site mutations in the ornithine transcarbamylase gene
Elisabeth Oppliger Leibundgut, B. Wermuth, J. Colombo, S. Liechti‐Gallati
1996Human Genetics6 citations
Semantic Scholar
CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms.
Elisabeth Oppliger Leibundgut, Daniela Rogenmoser-Dissler, D. D. De Beer, N. Porret +5 more
2012Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis5 citations
Semantic Scholar
Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias
Ekaterina Rebmann Chigrinova, N. Porret, M. Andres, Gertrud Wiedemann +6 more
2022BMC Medical Genomics4 citations Open access
Semantic Scholar
Higher Age (≥60 Years) Increases the Risk for Adverse Events during Autologous Hematopoietic Stem Cell Transplantation
M. Haubitz, Vittoria S. von Petersdorff, I. Helsen, C. Brunold +2 more
2023Cancers1 citations Open access
Semantic Scholar
Correlation between the Degree of Bone Marrow Involvement and the Results of NGS in Plasma Cell Neoplasms
Ekaterina Rebmann Chigrinova, N. Porret, Gertrud Wiedemann, M. Andres +6 more
20200 citations
Semantic Scholar
[Molecular analyses for (early) recognition of hematologic diseases - sense and sensibility for molecular analysis: the art of intelligent decision-making].
G. Baerlocher, Elisabeth Oppliger Leibundgut
2010Therapeutische Umschau. Revue thérapeutique0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Baerlocher×7
Invite
G. Baerlocher — researcher profile on SciRah
N. Porret×5
Invite
N. Porret — researcher profile on SciRah
A. Röth×3
Invite
A. Röth — researcher profile on SciRah
M. Haubitz×3
Invite
M. Haubitz — researcher profile on SciRah

×3

Invite

T. Pabst — researcher profile on SciRah

B. Burington×2

Invite

B. Burington — researcher profile on SciRah

S. Langabeer×2

Invite

S. Langabeer — researcher profile on SciRah

H. Andrikovics×2

Invite

H. Andrikovics — researcher profile on SciRah

Invite

J. Asp — researcher profile on SciRah

B. Bellosillo×2

Invite

B. Bellosillo — researcher profile on SciRah

Invite

K. Haslam — researcher profile on SciRah

Invite

E. Lippert — researcher profile on SciRah